Skip to content

MDCX MEDICUS PHARMA LTD

Follow

Common Shares, no par value (common), issuer CIK 1997296

Filings received so far for Q3 2026: 1 13F filer report a position in MDCX shares at 2026-09-30. The quarter is not complete: its 13F deadline is 2026-11-14, and the counts grow as filings arrive.

13D and 13G filers

Each filer's latest stake. The shares are the aggregate the reporting persons state, which can include entities that file no 13F.

Insider trades

The latest Form 4 transactions, non-derivative.
OwnerDateSharesPriceFiling
Smith Andrew Alasdairofficer (Chief Operating Officer)2026-11-13+14,534 A$1.72Form 4
Mehmud Faisalofficer (Chief Medical Officer)2026-11-13+14,534 A$1.72Form 4
May Sara R.director2026-11-13+5,813 A$1.72Form 4
MAHAFFY PATRICK Jdirector2026-11-13+14,534 A$1.72Form 4
Kaiser Larrydirector2026-11-13+14,534 A$1.72Form 4
Ciaruffoli Robert J.director2026-11-13+72,674 A$1.72Form 4
Brennan Edward J.officer (SVP, Medical Affairs)2026-11-13+14,534 A$1.72Form 4
Bonner Carolyn F.officer (President and CFO)2026-11-13+29,069 A$1.72Form 4
Bokhari Razadirector, officer (Chief Executive Officer), 10% owner2026-11-13+436,046 A$1.72Form 4

13F holders, Q3 2026

Filers in the available 13F reports with a share position at 2026-09-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.

HolderSharesValue% of portfolioChangeSource
STALEY CAPITAL ADVISERS INC10,000$1.61K<0.01%new13F-HRTimeline

Events

  • Smith Andrew Alasdair acquired 14,534 MDCX shares on 2026-11-13, Form 4 filed 2026-11-17. 0000950142-26-003111

    Accepted , ingested
  • Mehmud Faisal acquired 14,534 MDCX shares on 2026-11-13, Form 4 filed 2026-11-17. 0000950142-26-003110

    Accepted , ingested
  • May Sara R. acquired 5,813 MDCX shares on 2026-11-13, Form 4 filed 2026-11-17. 0000950142-26-003109

    Accepted , ingested
  • MAHAFFY PATRICK J acquired 14,534 MDCX shares on 2026-11-13, Form 4 filed 2026-11-17. 0000950142-26-003108

    Accepted , ingested
  • Kaiser Larry acquired 14,534 MDCX shares on 2026-11-13, Form 4 filed 2026-11-17. 0000950142-26-003107

    Accepted , ingested
  • Ciaruffoli Robert J. acquired 72,674 MDCX shares on 2026-11-13, Form 4 filed 2026-11-17. 0000950142-26-003106

    Accepted , ingested
  • Brennan Edward J. acquired 14,534 MDCX shares on 2026-11-13, Form 4 filed 2026-11-17. 0000950142-26-003105

    Accepted , ingested
  • Bonner Carolyn F. acquired 29,069 MDCX shares on 2026-11-13, Form 4 filed 2026-11-17. 0000950142-26-003104

    Accepted , ingested
  • Bokhari Raza acquired 436,046 MDCX shares on 2026-11-13, Form 4 filed 2026-11-17. 0000950142-26-003103

    Accepted , ingested
  • Melani Kenneth R. and 1 other reporting person reported 3,248,741 MDCX shares, 3.6% of the class, as of 2026-09-30, in a 13G/A filed 2026-10-16. 0000950142-26-002781

    Accepted , ingested